Anti-TROP2 antibody
Grant
US12577319B2
Kind: B2
Mar 17, 2026
Assignee
SYSTIMMUNE, INC.
Inventors
Yi Zhu, Yong Zhang, Shi Zhuo, Muran Ding, Zun Wang
Abstract
The present disclosure relates to antibodies, in particular monoclonal antibodies of murine, chimeric, and humanized origin, that specifically bind to the human TROP2 protein, and to the amino acid and nucleotide sequences encoding these antibodies. The disclosure also discloses the use of these antibodies as a diagnostic reagent or a drug in the diagnostic and/or therapeutic management of malignancies or any lesion related to the overexpression of the receptor.
CPC Classifications
C07K 16/30
Filing Date
2021-06-18
Application No.
18011175
Claims
19